
|Articles|June 29, 2017
Santhera Selects Veeva Systems for Product Launch
Advertisement
Santhera Pharmaceuticals, rare disease pharmaceutical company, has selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The platform will be used to help Santhera establish a consistent, global approach to commercialization as it offers up-to-date customer reference data for field teams to enable faster, tailored interactions with HCPs.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
2
When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026
3
FDA Reveals New Guidance for Streamlining Biosimilar Development
4
What Risks and Opportunities Does FDA's Single-Trial Approval Pathway Create?
5




